543595
EPBIO
Start SIP
Invest Now
Start SIP in EPBIO
EP Biocomposites live price: ₹99.1. It opened at ₹99 vs previous close ₹96; intraday high/low: ₹99/₹99. The 50 & 200 DMA stand at ₹103.34/₹126.21.
EP Biocomposites Performance
- Low
- ₹99
- High
- ₹99
- 52 Week Low
- ₹90
- 52 Week High
- ₹150
- Open Price₹99
- Previous Close₹96
- Volume500
- 50 DMA₹103.34
- 100 DMA₹111.83
- 200 DMA₹126.21
Investment Returns
- Over 1 Month + 1.12%
- Over 3 Month -0.85%
- Over 6 Month -19.46%
- Over 1 Year -11%
Smart Investing Starts Here Start SIP with EP Biocomposites for Steady Growth!
EP Biocomposites Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.2
- PEG Ratio
- -
- Market Cap Cr
- 17
- P/B Ratio
- 1.6
- Average True Range
- 6.05
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -2.22
- RSI
- 50.22
- MFI
- 46.72
EP Biocomposites Financials
EP Biocomposites Technicals
EMA & SMA
Current Price
₹99.10
+
3.1
(3.23%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹97.67
- 50 Day
- ₹103.34
- 100 Day
- ₹111.83
- 200 Day
- ₹126.21
Resistance and Support
99.1
- R3 99.10
- R2 99.10
- R1 99.10
- S1 99.10
- S2 99.10
- S3 99.10
EP Biocomposites Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-03 | Half Yearly Results | |
| 2025-05-23 | Half Yearly Results | |
| 2024-11-13 | Half Yearly Results | |
| 2024-05-24 | Audited Results | |
| 2023-11-14 | Half Yearly Results |
EP Biocomposites F&O
About EP Biocomposites
- NSE Symbol
- EPBIO
- BSE Symbol
- 543595
- Managing Director
- Mr. Rajkumar Gajanan Kamat
- ISIN
- INE0D2I01014
Similar Stocks to EP Biocomposites
EP Biocomposites FAQs
EP Biocomposites share price is ₹99 As on 15 March, 2026 | 18:02
The Market Cap of EP Biocomposites is ₹16.7 Cr As on 15 March, 2026 | 18:02
The P/E ratio of EP Biocomposites is 16.2 As on 15 March, 2026 | 18:02
The PB ratio of EP Biocomposites is 1.6 As on 15 March, 2026 | 18:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.